Medicare Advantage Denials in 2026: How to Appeal Prior Authorization Rejections and Protect Your Coverage

Medicare Advantage now covers more than 33 million Americans, or roughly 54 percent of the Medicare-eligible population, according to the KFF Medicare Advantage tracker. That growth has been paralleled by a sharp rise in prior authorization denials. A 2024 review by the Office of Inspector General at the U.S. Department of Health and Human Services found that Medicare Advantage plans denied 6 percent of prior authorization requests overall, but that 13 percent of denials would have been approved under traditional Medicare rules had the beneficiary been enrolled in Original Medicare instead.

For seniors and Americans with disabilities enrolled in Medicare Advantage, an unexpected denial of coverage for a hospital admission, a skilled nursing facility stay, a specialty medication, or a diagnostic imaging study can turn a routine medical event into a financially catastrophic one. The good news is that federal law guarantees every Medicare Advantage enrollee a five-level appeal process with defined timelines, and roughly 80 percent of appeals that reach a full reconsideration are decided at least partially in the beneficiary's favor.

This guide explains, in factual and neutral terms, how the 2026 Medicare Advantage denial and appeal system works, what protections the Centers for Medicare & Medicaid Services (CMS) enforce, when to involve an elder-law or health-insurance attorney, and how supplemental insurance products interact with denials that expose beneficiaries to out-of-pocket cost.

Table of Contents

• Medicare Advantage vs. Original Medicare in 2026
• Prior Authorization: The Most Common Denial Trigger
• Types of Denials You May Receive
• How to Read a Notice of Denial of Medical Coverage
• The Five-Level Appeal Process
• Expedited Appeals for Urgent Care
• Building the Medical Evidence File
• New 2026 CMS Rules on Coverage Criteria
• Special Rules for Skilled Nursing Facility Denials
• Part D Prescription Drug Denials and Formulary Exceptions
• When to Consult an Elder-Law or Health-Insurance Attorney
• Supplemental Insurance and the Denial Gap
• Frequently Asked Questions

Medicare Advantage vs. Original Medicare in 2026

Medicare Advantage plans, known formally as Medicare Part C, are private health plans that contract with CMS to provide the same Part A hospital and Part B medical benefits that Original Medicare covers, and most also include Part D prescription drug coverage and additional benefits such as dental, vision, hearing, and fitness memberships. In exchange for the added benefits and often a $0 premium, enrollees generally accept a defined provider network and a prior authorization framework that Original Medicare does not use for most services.

Under Original Medicare, prior authorization applies to a small and defined list of items and services, primarily durable medical equipment and certain hospital outpatient procedures. Under Medicare Advantage, prior authorization is far broader. The KFF analysis of 2023 plan data found that on average each Medicare Advantage enrollee had 2.0 prior authorization requests submitted on their behalf during the year, and that requests were most concentrated in high-cost service categories such as inpatient hospital care, skilled nursing facility care, diagnostic imaging, and oncology drugs.

Prior Authorization: The Most Common Denial Trigger

Prior authorization is the process by which the plan reviews a proposed service before it is delivered and issues an approval, a partial approval, or a denial. Denials at this stage do not require any billing dispute, because no service has been provided; they simply block or delay the requested care.

Common reasons cited by Medicare Advantage plans for prior authorization denials include:

• Not medically necessary. The plan's clinical reviewers determined the requested service does not meet the plan's coverage criteria or internal clinical guidelines.
• Not the least-costly alternative. The plan believes a less expensive service (for example, physical therapy in place of MRI, or oral medication in place of infused therapy) should be tried first.
• Out-of-network provider. The requesting provider is not contracted with the plan, and the plan does not consider the service to require an out-of-network exception.
• Documentation insufficient. The clinical records submitted did not include the specific findings the plan's utilization management protocol requires.
• Site-of-service policy. The plan will pay for the service only in a specific setting (outpatient rather than inpatient, ambulatory surgical center rather than hospital) and denied the requested setting.

Types of Denials You May Receive

Not every "no" from a Medicare Advantage plan is a formal denial subject to the same appeal process. Understanding which document you have received is the first step in preserving your rights.

How to Read a Notice of Denial of Medical Coverage

The Integrated Denial Notice is a standardized CMS form, and every field carries meaning. Beneficiaries should confirm the following elements before beginning an appeal:

• The date on the notice and the date the beneficiary actually received it. Filing deadlines run from receipt, and mail is presumed received five days after the date on the notice unless proven otherwise.
• The specific service, item, or medication that was denied, together with any CPT, HCPCS, or NDC code cited.
• The rule, coverage policy, or clinical criterion the plan applied. Federal regulations at 42 CFR 422.568 require the plan to cite the specific reason for the denial in language the beneficiary can understand.
• The identity of the reviewer, including credentials if a peer-to-peer review was conducted.
• The specific appeal instructions, including the address, fax number, and online portal for filing a reconsideration.

The Five-Level Appeal Process

Federal law guarantees Medicare Advantage enrollees five levels of appeal. Each level has a defined decision-maker, a defined standard of review, and a defined timeframe. The stages are:

Level 1: Reconsideration by the Plan

The beneficiary requests that the plan reconsider its own denial. The plan must decide standard requests within 30 days (or 60 days for payment claims) and expedited requests within 72 hours. If the plan upholds its denial in whole or in part, the case is automatically forwarded to Level 2 without additional action by the beneficiary.

Level 2: Independent Review Entity (IRE)

An IRE contracted by CMS conducts an independent reconsideration. Standard decisions are due in 30 days; expedited decisions in 72 hours. The IRE has no financial relationship with the plan and applies national Medicare coverage rules together with the plan's stated criteria.

Level 3: Office of Medicare Hearings and Appeals (OMHA)

If the disputed amount reaches the annually adjusted threshold ($190 for 2026) and the beneficiary requests further review within 60 days, an Administrative Law Judge (ALJ) conducts a hearing, typically by telephone or video. This is the first stage at which the beneficiary can testify and question witnesses. Decisions are due within 90 days.

Level 4: Medicare Appeals Council

The Departmental Appeals Board of HHS reviews the ALJ decision for legal error. Decisions are due within 90 days.

Level 5: Federal District Court

If the amount in controversy meets a separate threshold ($1,900 for 2026) and administrative remedies have been exhausted, the beneficiary may file suit in federal district court. Judicial review focuses on whether the Council's decision was arbitrary, capricious, unsupported by substantial evidence, or contrary to law.

Expedited Appeals for Urgent Care

Any beneficiary or physician who believes that the standard 30-day or 60-day appeal timeframe could seriously jeopardize the beneficiary's life, health, or ability to regain maximum function may request an expedited appeal. When the treating physician submits the request or supports it in writing, the plan is required to treat the request as expedited without a separate review. The plan or IRE must issue a decision within 72 hours.

Expedited review applies at Levels 1 and 2. From Level 3 onward, standard timeframes apply, though ALJs may in urgent cases advance the hearing on the docket.

Building the Medical Evidence File

Appeals succeed or fail primarily on the strength of the medical record. Beneficiaries and their treating providers should assemble the following before submitting the reconsideration request:

• The complete relevant progress notes from the treating physician documenting the diagnosis, prior treatments attempted, and the clinical rationale for the requested service.
• Any diagnostic test results, imaging reports, or laboratory values that support medical necessity.
• A letter of medical necessity from the treating provider that specifically addresses each reason cited in the denial notice.
• Any relevant national coverage determinations (NCDs), local coverage determinations (LCDs), or specialty-society clinical guidelines that support coverage.
• For denials citing internal plan criteria, a written request for the specific criteria used, which the plan must produce under 42 CFR 422.568(f).

New 2026 CMS Rules on Coverage Criteria

Effective January 1, 2024 and further refined for the 2026 plan year, CMS issued a final rule that limits how Medicare Advantage plans may apply internal coverage criteria. Under 42 CFR 422.101(b), a Medicare Advantage plan must:

• Follow all Medicare national coverage determinations (NCDs), local coverage determinations (LCDs), and general coverage and benefit conditions.
• Provide coverage for any service the plan determines is medically necessary based on the individual's medical history, physician recommendations, or clinical notes.
• Only apply internal coverage criteria in circumstances where the coverage criteria are not fully established under NCDs, LCDs, or Medicare statute and regulation, and only after making the criteria publicly available.

This rule was cited by CMS as a direct response to Office of Inspector General findings that some plans were using proprietary artificial intelligence algorithms to deny care that Original Medicare would have covered. The 2026 rule also confirms that a Medicare Advantage plan may not use an algorithm as the sole basis for a coverage denial without individualized clinical review by a qualified reviewer.

Special Rules for Skilled Nursing Facility Denials

Skilled nursing facility (SNF) coverage is one of the most frequently denied benefits and one of the most litigated. Under Original Medicare, up to 100 days of SNF care per benefit period is covered following a qualifying three-day inpatient hospital stay. Medicare Advantage plans generally offer the same 100-day maximum but often waive the three-day rule.

When a Medicare Advantage plan issues a Notice of Medicare Non-Coverage (NOMNC) terminating SNF, home health, or comprehensive outpatient rehabilitation facility (CORF) services, the beneficiary has the right to request an expedited review by the Beneficiary and Family Centered Care Quality Improvement Organization (BFCC-QIO). The request must be made by noon the day before services are scheduled to end, and if made in time, the plan is required to continue coverage while the review is pending, with limited exceptions for reimbursement.

The Jimmo v. Sebelius settlement remains binding in 2026: coverage of skilled maintenance therapy cannot be denied solely because a beneficiary's condition is chronic, stable, or not expected to improve. Coverage depends on whether skilled care is needed, not on whether improvement is expected.

Part D Prescription Drug Denials and Formulary Exceptions

Prescription drug denials under a Medicare Advantage Part D benefit follow a parallel but distinct appeal track. When a pharmacy tells a beneficiary at the counter that the drug is not covered or requires prior authorization, the beneficiary is entitled to a written coverage determination on request. From that determination, the redetermination request (Level 1) must be filed within 60 days, and the plan must decide within 7 days for standard requests or 72 hours for expedited requests.

Formulary exceptions are available when the beneficiary's prescriber certifies in writing that all covered alternatives on the formulary would not be as effective, would have adverse effects, or both. A tier-cost exception may reduce the beneficiary's copayment when a lower-tier alternative is not clinically appropriate.

When to Consult an Elder-Law or Health-Insurance Attorney

Beneficiaries can navigate Levels 1 and 2 without an attorney, and free assistance is available from every State Health Insurance Assistance Program (SHIP) through Medicare.gov. Legal representation becomes valuable in the following circumstances:

• The disputed amount is high (skilled nursing facility stays, oncology therapy, high-cost specialty drugs, complex inpatient admissions).
• The plan has denied coverage citing an internal algorithm or a proprietary clinical guideline the beneficiary cannot obtain.
• The case involves the termination of ongoing services and the beneficiary needs an emergency injunction or continued coverage during appeal.
• The appeal has reached the ALJ stage (Level 3), where evidentiary rules, hearing procedure, and legal argument become material.
• The denial appears to violate the Mental Health Parity and Addiction Equity Act, the Americans with Disabilities Act, or Section 1557 of the Affordable Care Act.

Related coverage on Trust All America explores appealing mental health parity denials, rights under the No Surprises Act, and a broader comparison of Medicare plan options.

Supplemental Insurance and the Denial Gap

Medicare Advantage enrollees generally cannot purchase a Medigap policy to fill out-of-pocket exposure, because Medigap is designed for Original Medicare. However, several product categories can help manage financial risk from denials or partial coverage:

• Hospital indemnity insurance pays a fixed cash benefit per day of inpatient admission, regardless of whether the hospital stay is later denied.
• Critical illness insurance pays a lump sum on diagnosis of a covered condition and can fund out-of-pocket costs during a lengthy appeal.
• Cancer or specified-disease policies supplement coverage for high-cost oncology care, including therapies frequently subject to prior authorization.
• Long-term care insurance covers custodial nursing home and home-care services that Medicare Advantage generally does not, avoiding coverage-gap disputes at the boundary between skilled and custodial care.

Beneficiaries considering a switch back to Original Medicare (available annually during the Medicare Advantage Open Enrollment Period from January 1 to March 31, or during the Fall Annual Enrollment Period from October 15 to December 7) should verify Medigap underwriting rules in their state, because outside of guaranteed-issue windows insurers may impose medical underwriting.

Frequently Asked Questions

What percentage of Medicare Advantage appeals are successful?

According to the CMS Medicare Advantage appeals data summarized by KFF, roughly 80 percent of appeals that reach a full reconsideration are decided at least partially in the beneficiary's favor. Only about 10 percent of denials are ever appealed, so most reversible denials go uncontested.

How long do I have to appeal a Medicare Advantage denial?

The standard filing deadline is 60 days from the date the beneficiary receives the denial notice, at each of the first four appeal levels. Extensions are available for good cause under 42 CFR 422.582.

Can my doctor request an expedited appeal on my behalf?

Yes. When the treating physician submits a written statement that the standard timeframe could seriously jeopardize the beneficiary's health, the plan is required to expedite the review without further evaluation of the urgency request.

Does the plan have to keep paying while I appeal a termination of skilled nursing care?

Yes, if the beneficiary requests an expedited BFCC-QIO review by noon the day before services are scheduled to end. If the request is timely, the plan continues coverage while the review is pending, subject to limited reimbursement rules if coverage is later denied.

Can Medicare Advantage plans use AI algorithms to deny care?

Under the 2024 and 2026 CMS rules, a Medicare Advantage plan may not use an algorithm as the sole basis for a coverage denial. An individualized clinical review by a qualified reviewer is required, and internal criteria may only be applied where NCDs, LCDs, and Medicare statute do not fully establish coverage.

What is the difference between a coverage determination and a claim denial?

A coverage determination (or organization determination) is issued before or during the delivery of care and addresses whether the plan will pay. A claim denial is issued after a claim has been submitted for a service already provided. Both are appealable through the five-level process, but the timing and posture of the appeal differ.

Do I need a lawyer to file a Medicare Advantage appeal?

No. Beneficiaries can file at every level without counsel. Free assistance is available through the State Health Insurance Assistance Program (SHIP) in every state and territory. Legal counsel is most useful at the ALJ level or when the case involves an emergency injunction, complex regulatory arguments, or a large disputed amount.

Can I switch from Medicare Advantage back to Original Medicare after a bad experience?

Yes, during the Medicare Advantage Open Enrollment Period (January 1 to March 31) or the Fall Annual Enrollment Period (October 15 to December 7). Note that outside guaranteed-issue windows, purchasing a Medigap policy to supplement Original Medicare may require medical underwriting, which can result in higher premiums or denial of a Medigap policy for pre-existing conditions.

Disclaimer: This article is provided for general informational purposes only and does not constitute legal, medical, or insurance advice. Medicare Advantage rules, plan-specific coverage criteria, and appeal deadlines change periodically. Readers who have received a denial notice should review the specific instructions on the notice, contact their State Health Insurance Assistance Program (SHIP), and consider consulting a licensed elder-law or health-insurance attorney before making decisions. Source figures are drawn from the Centers for Medicare & Medicaid Services, the U.S. Department of Health and Human Services Office of Inspector General, and KFF as of publication and are subject to update.